世界の感染症分子診断市場は、2023年に約520億米ドルと評価され、2024年から2032年の予測期間にわたって3.9％を超える健全な成長率で成長すると予想されています。世界的に感染症の蔓延が増加していることと、分子診断技術の進歩が相まって、市場の成長を牽引しています。特に新たな感染の脅威を受けて、迅速かつ正確な疾患検出方法の需要が高まっており、次世代シーケンシング（NGS）、ポリメラーゼ連鎖反応（PCR）、CRISPRベースの診断プラットフォームへの投資が促進されています。さらに、技術革新により、診断検査の精度、速度、アクセス性が大幅に向上し、医療提供者はデータに基づいて治療を決定できるようになりました。
結核、肝炎、性感染症（STI）、呼吸器疾患、抗菌薬耐性感染症などの疾患の発生率の上昇により、分子診断の採用が加速しています。感染症の研究、臨床試験、革新的な診断ツールに対する政府および民間部門の資金提供により、市場拡大がさらに加速しています。たとえば、2025年1月、ロードアイランド病院（Rhode Island Hospital）は、肺炎を引き起こす細菌の血液から直接PCR検査を開発するために、CARB-Xから100万ドルの助成金を獲得しました。同様に、Kryptos Biotechnologiesは、STIの迅速なマルチプレックス分子診断技術を進歩させるために120万ドルの資金を受け取りました。これらの取り組みは、感染症の発生を抑制し、患者の転帰を改善するための精密診断への注目が高まっていることを強調しています。
地理的に見ると、北アメリカが感染症分子診断市場を支配し、2024年には収益シェアの40.95%を占めました。この地域の診断技術における強固な基盤、堅牢な医療インフラ、迅速な検査ソリューションに対する高い需要が、同地域の市場リーダーシップに貢献しています。アジア太平洋地域は、疾患の蔓延の増加、診断インフラへの投資の増加、疾患の早期発見に対する意識の高まりにより、予測期間中に最も速いCAGRが見込まれています。中国、インド、日本などの国では、患者人口の多さ、医療革新に対する政府の資金提供、在宅およびポイントオブケア（PoC）検査ソリューションの進歩により、分子診断検査の需要が急増しています。
分子診断における人工知能（AI）とデジタルヘルスプラットフォームの採用の増加により、市場の状況が一変すると予想されています。AI駆動型診断ツールは、病原体検出の精度と効率を高め、誤検出を減らし、診断の信頼性を向上させます。さらに、クラウドベースの診断プラットフォームは、リアルタイムの疾病監視とアウトブレイク管理を合理化しています。診断技術の継続的な革新と、公共部門と民間部門の組織間の連携の増加により、感染症分子診断市場は予測期間を通じて持続的な成長を遂げる態勢が整っています。
目次
Table of Contents
Chapter 1. Global Infectious Disease Molecular Diagnostics Market Executive Summary
1.1. Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.2. By Technology
1.3.3. By Application
1.3.4. By End-Use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Infectious Disease Molecular Diagnostics Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Infectious Disease Molecular Diagnostics Market Dynamics
3.1. Market Drivers
3.1.1. Rising Prevalence of Infectious Diseases Worldwide
3.1.2. Technological Advancements in Molecular Diagnostics
3.1.3. Growing Adoption of Point-of-Care Testing
3.2. Market Challenges
3.2.1. High Cost of Molecular Diagnostic Tests
3.2.2. Regulatory Hurdles and Stringent Approval Processes
3.3. Market Opportunities
3.3.1. Expansion in Emerging Markets
3.3.2. Increasing Focus on Personalized Medicine
Chapter 4. Global Infectious Disease Molecular Diagnostics Market Industry Analysis
4.1. Porter’s Five Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s Five Force Model
4.1.7. Porter’s Five Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political Factors
4.2.2. Economic Factors
4.2.3. Social Factors
4.2.4. Technological Factors
4.2.5. Environmental Factors
4.2.6. Legal Factors
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Infectious Disease Molecular Diagnostics Market Size & Forecasts by Product (2022-2032)
5.1. Segment Dashboard
5.2. Market Revenue Trend Analysis (USD Billion)
5.2.1. Instruments
5.2.2. Reagents
5.2.3. Services
Chapter 6. Global Infectious Disease Molecular Diagnostics Market Size & Forecasts by Technology (2022-2032)
6.1. Segment Dashboard
6.2. Market Revenue Trend Analysis (USD Billion)
6.2.1. Polymerase Chain Reaction (PCR)
6.2.2. In Situ Hybridization
6.2.3. Isothermal Nucleic Acid Amplification Technology (INAAT)
6.2.4. Chips and Microarrays
6.2.5. Mass Spectrometry
6.2.6. Transcription Mediated Amplification
6.2.7. Others
Chapter 7. Global Infectious Disease Molecular Diagnostics Market Size & Forecasts by Application (2022-2032)
7.1. Segment Dashboard
7.2. Market Revenue Trend Analysis (USD Billion)
7.2.1. Respiratory Diseases
7.2.2. Tuberculosis
7.2.3. Meningitis
7.2.4. Gastrointestinal Tract Infections
7.2.5. Human Papillomavirus (HPV)
7.2.6. Sexually Transmitted Infections
7.2.7. Sepsis
7.2.8. Drug Resistance Diseases
7.2.9. Others
Chapter 8. Global Infectious Disease Molecular Diagnostics Market Size & Forecasts by End-Use (2022-2032)
8.1. Segment Dashboard
8.2. Market Revenue Trend Analysis (USD Billion)
8.2.1. Hospitals
8.2.2. Clinics
8.2.3. Diagnostic Laboratories
8.2.4. Research Institutes
Chapter 9. Global Infectious Disease Molecular Diagnostics Market Size & Forecasts by Region (2022-2032)
9.1. North America
9.1.1. U.S.
9.1.2. Canada
9.1.3. Mexico
9.2. Europe
9.2.1. UK
9.2.2. Germany
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Denmark
9.2.7. Sweden
9.2.8. Norway
9.3. Asia-Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. Australia
9.3.5. South Korea
9.3.6. Thailand
9.4. Latin America
9.4.1. Brazil
9.4.2. Argentina
9.5. Middle East & Africa
9.5.1. South Africa
9.5.2. Saudi Arabia
9.5.3. UAE
9.5.4. Kuwait
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Danaher Corporation
10.1.2. Abbott Laboratories
10.1.3. Roche Diagnostics
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Abbott
10.3.2. Danaher Corporation
10.3.3. Bio-Rad Laboratories, Inc.
10.3.4. bioMérieux SA
10.3.5. F. Hoffmann-La Roche Ltd
10.3.6. Agilent Technologies, Inc.
10.3.7. Becton, Dickinson and Company
10.3.8. Hologic, Inc. (Gen-Probe)
10.3.9. Illumina, Inc.
10.3.10. Grifols S.A.
10.3.11. Qiagen
10.3.12. Siemens Healthineers AG
10.3.13. Sysmex Corporation
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
List of Tables
TABLE 1. Global Infectious Disease Molecular Diagnostics Market, Report Scope
TABLE 2. Global Infectious Disease Molecular Diagnostics Market Estimates & Forecasts by Region (2022-2032) (USD Million/Billion)
TABLE 3. Global Infectious Disease Molecular Diagnostics Market Estimates & Forecasts by Product (2022-2032) (USD Million/Billion)
TABLE 4. Global Infectious Disease Molecular Diagnostics Market Estimates & Forecasts by Technology (2022-2032) (USD Million/Billion)
TABLE 5. Global Infectious Disease Molecular Diagnostics Market Estimates & Forecasts by Application (2022-2032) (USD Million/Billion)
TABLE 6. Global Infectious Disease Molecular Diagnostics Market Estimates & Forecasts by End-Use (2022-2032) (USD Million/Billion)
TABLE 7. North America Infectious Disease Molecular Diagnostics Market, by Country, 2022-2032 (USD Million/Billion)
TABLE 8. Europe Infectious Disease Molecular Diagnostics Market, by Country, 2022-2032 (USD Million/Billion)
TABLE 9. Asia Pacific Infectious Disease Molecular Diagnostics Market, by Country, 2022-2032 (USD Million/Billion)
TABLE 10. Latin America Infectious Disease Molecular Diagnostics Market, by Country, 2022-2032 (USD Million/Billion)
TABLE 11. Middle East & Africa Infectious Disease Molecular Diagnostics Market, by Country, 2022-2032 (USD Million/Billion)
TABLE 12. Global Market Share of Leading Players, 2023 (%)
TABLE 13. Global Infectious Disease Molecular Diagnostics Market: Competitive Benchmarking
TABLE 14. Key Developments in the Market, 2022-2025
TABLE 15. Regulatory Landscape for Infectious Disease Molecular Diagnostics Market by Region
TABLE 16. Market Trends and Growth Opportunities in Infectious Disease Molecular Diagnostics
TABLE 17. Impact of COVID-19 on the Infectious Disease Molecular Diagnostics Market
TABLE 18. Key Funding and Investment Activities in the Market (2022-2025)
TABLE 19. Pricing Analysis of Molecular Diagnostic Tests by Region (2022-2032)
TABLE 20. Key Strategies Adopted by Market Players (2022-2025)
This list is not complete. The final report contains more than 100 tables. The list may be updated in the final deliverable.
List of Figures
FIGURE 1. Global Infectious Disease Molecular Diagnostics Market, Research Methodology
FIGURE 2. Global Infectious Disease Molecular Diagnostics Market, Market Estimation Techniques
FIGURE 3. Global Market Size Estimates & Forecast Methods
FIGURE 4. Key Trends in the Global Infectious Disease Molecular Diagnostics Market, 2023
FIGURE 5. Global Infectious Disease Molecular Diagnostics Market Growth Prospects (2022-2032)
FIGURE 6. Global Infectious Disease Molecular Diagnostics Market, Porter’s Five Forces Model
FIGURE 7. Global Infectious Disease Molecular Diagnostics Market, PESTEL Analysis
FIGURE 8. Global Infectious Disease Molecular Diagnostics Market, Value Chain Analysis
FIGURE 9. Global Infectious Disease Molecular Diagnostics Market, Revenue Share by Product (2023)
FIGURE 10. Global Infectious Disease Molecular Diagnostics Market, Revenue Share by Technology (2023)
FIGURE 11. Global Infectious Disease Molecular Diagnostics Market, Revenue Share by Application (2023)
FIGURE 12. Global Infectious Disease Molecular Diagnostics Market, Revenue Share by End-Use (2023)
FIGURE 13. North America Infectious Disease Molecular Diagnostics Market Revenue Share (2023)
FIGURE 14. Europe Infectious Disease Molecular Diagnostics Market Revenue Share (2023)
FIGURE 15. Asia Pacific Infectious Disease Molecular Diagnostics Market Revenue Share (2023)
FIGURE 16. Latin America Infectious Disease Molecular Diagnostics Market Revenue Share (2023)
FIGURE 17. Middle East & Africa Infectious Disease Molecular Diagnostics Market Revenue Share (2023)
FIGURE 18. Market Share Analysis of Key Players in the Global Infectious Disease Molecular Diagnostics Market (2023)
FIGURE 19. Investments and Funding in Infectious Disease Molecular Diagnostics (2022-2025)
FIGURE 20. Key Strategic Developments in the Infectious Disease Molecular Diagnostics Market (2022-2025)
This list is not complete. The final report contains more than 50 figures. The list may be updated in the final deliverable.
